MECHANISM OF HUMAN LEUKOCYTE CHEMOTAXIS
人类白细胞趋化机制
基本信息
- 批准号:3133365
- 负责人:
- 金额:$ 11.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-07-01 至 1989-06-30
- 项目状态:已结题
- 来源:
- 关键词:bactericidal immunity burns cell migration chemotaxis complement electron microscopy fatty acids flow cytometry free radicals hemolysin human subject leukotrienes myeloperoxidase neutrophil nuclear magnetic resonance spectroscopy peptides peritonitis phagocytic dysfunction platelet activating factor platelet derived growth factor radioimmunoassay staphylococcal exotoxin succinates superoxides tissue /cell culture
项目摘要
The long term objectives of the proposed research are to identify
mechanisms of loss of human neutrophil chemotactic function which occurs in
association with thermal injury and intra-abdominal infection and to
identify treatments which will restore chemotactic function or prevent its
loss. Specific aims in this application include: (1) supplementation of
laboratory methods available to include the multiwell chamber membrane
filter technique, to add three or chemoattractants to better consider the
breadth of loss of patient neutrophil chemotactic function, and to develop
methods to identify and physically isolate subpopulations of neutrophils;
(2) continue our studies of patient neutrophil chemotactic dysfunction to
verify our preliminary observation that the complement cascade is activated
in plasma following thermal injury and during infection and that exposure
of neutrophils to products of complement activation is in part responsible
for loss of chemotactic migratory function; (3) continue our studies of
control neutrophils to identify in vitro treatment conditions which alter
both random and chemotactic migratory functions, to verify the role of
oxygen metabolites in loss of random motility, and to model defects
identified for patient neutrophil chemotactic function; and (4) to begin to
consider in vitro conditions or treatments of patient neutrophils which
restore chemotactic function.
Host defense against infection involves several types of phagocytes and
multiple cellular activities of these cells related to microbicidal
function. Neutrophil chemotactic function is essential to the primary role
of these cells in host defense against infection. There is much evidence
to demonstrate that impaired motility alone may be sufficient to affect
host defenses adversely. With the exception of several inherited disorders
of neutrophil migratory function, mechanisms of loss of neutrophil
chemotactic function in other situations remain poorly understood. We
expect that information generated from experiments described in this
application will add to our understanding of mechanisms of loss of
neutrophil chemotactic function in thermal injury and infection.
Information obtained will also have application to identification of
treatments to prevent chemotactic dysfunction in these situations, to
understanding monocyte and macraphage migratory functions, and to providing
background for studies of complement activation in vivo and the role of
products of complement activation in modulation of immune function in
infection and cancer.
拟议研究的长期目标是确定
人中性粒细胞趋化功能丧失的机制
与热损伤和腹内感染的关系
确定可以恢复趋化功能或防止其
损失。本申请的具体目的包括:(1)补充
可用于包括多孔室膜的实验室方法
过滤技术,加入三种或三种化学吸引剂,以更好地考虑
患者中性粒细胞趋化功能丧失的广度,并发展
方法鉴定和物理分离中性粒细胞亚群;
(2)继续我们对患者中性粒细胞趋化功能障碍的研究
证实我们的初步观察,补体级联被激活
在热损伤后以及在感染和暴露期间血浆中
中性粒细胞对补体激活产物的作用是部分原因
对于丧失趋化迁移功能;(3)继续我们的研究
控制中性粒细胞以确定在体外治疗条件下
兼具随机性和趋化性迁移功能,验证其作用
氧代谢产物在随机运动性丧失和模型缺陷中的作用
确定患者中性粒细胞趋化功能;以及(4)开始
考虑患者中性粒细胞的体外条件或治疗
恢复趋化功能。
宿主对感染的防御涉及几种类型的吞噬细胞和
这些细胞的多种细胞活性与杀灭微生物有关
功能。中性粒细胞趋化功能是必不可少的首要作用
这些细胞在宿主防御感染中的作用。有很多证据表明
来证明仅是运动能力受损就足以影响
主机的防御是不利的。除了几种遗传性疾病
中性粒细胞迁移功能、中性粒细胞丢失机制的研究
其他情况下的趋化功能仍然知之甚少。我们
期望通过本文件中描述的实验生成的信息
应用将增加我们对损失机制的理解。
中性粒细胞在烫伤和感染中的趋化作用。
所获得的信息也将适用于识别
在这些情况下预防趋化功能障碍的治疗,以
了解单核细胞和巨噬细胞的迁移功能,并为
补体激活的体内研究背景及补体的作用
补体激活产物在免疫功能调节中的作用
感染和癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT D NELSON其他文献
ROBERT D NELSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT D NELSON', 18)}}的其他基金
CANDIDIASIS--IMMUNO-INHIBITION BY MANNAN CATABOLITES
念珠菌病--甘露聚糖分解代谢物的免疫抑制
- 批准号:
3139454 - 财政年份:1988
- 资助金额:
$ 11.79万 - 项目类别:
CANDIDIASIS--IMMUNO-INHIBITION BY MANNAN CATABOLITES
念珠菌病--甘露聚糖分解代谢物的免疫抑制
- 批准号:
3139455 - 财政年份:1988
- 资助金额:
$ 11.79万 - 项目类别:
CANDIDIASIS--IMMUNO-INHIBITION BY MANNAN CATABOLITES
念珠菌病--甘露聚糖分解代谢物的免疫抑制
- 批准号:
3139453 - 财政年份:1988
- 资助金额:
$ 11.79万 - 项目类别:
CANDIDIASIS--IMMUNO-INHIBITION BY MANNAN CATABOLITES
念珠菌病--甘露聚糖分解代谢物的免疫抑制
- 批准号:
3139450 - 财政年份:1988
- 资助金额:
$ 11.79万 - 项目类别:
CANDIDIASIS--IMMUNO-INHIBITION BY MANNAN CATABOLITES
念珠菌病--甘露聚糖分解代谢物的免疫抑制
- 批准号:
3139456 - 财政年份:1988
- 资助金额:
$ 11.79万 - 项目类别:
相似海外基金
Designing a multifaceted, community-driven, behavioural change intervention to improve first response to childhood burns (Cool-Burn20)
设计多方面的、社区驱动的行为改变干预措施,以改善对儿童烧伤的第一反应 (Cool-Burn20)
- 批准号:
MR/Y503265/1 - 财政年份:2023
- 资助金额:
$ 11.79万 - 项目类别:
Research Grant
A recombinant elastin skin substitute for the treatment of burns
用于治疗烧伤的重组弹性蛋白皮肤替代品
- 批准号:
10601801 - 财政年份:2023
- 资助金额:
$ 11.79万 - 项目类别:
In Situ Skin Regeneration and Angiogenesis for Full-Thickness Burns
全层烧伤的原位皮肤再生和血管生成
- 批准号:
10587297 - 财政年份:2023
- 资助金额:
$ 11.79万 - 项目类别:
Towards Net-Zero Emissions by 2050: From What (Fuels) to How (Burns) (SHELL)
到 2050 年实现净零排放:从什么(燃料)到如何(燃烧)(壳牌)
- 批准号:
2745407 - 财政年份:2022
- 资助金额:
$ 11.79万 - 项目类别:
Studentship
Establishment of treatment for burns and traumatic skin defect wounds using epidermal growth factor-incorporating wound dressing.
建立使用含有表皮生长因子的伤口敷料治疗烧伤和创伤性皮肤缺损伤口的方法。
- 批准号:
22K16629 - 财政年份:2022
- 资助金额:
$ 11.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Boreal caribou movement in relation to forage availability and habitat structure within regenerating burns
北方驯鹿的运动与再生烧伤中的饲料供应和栖息地结构有关
- 批准号:
572802-2022 - 财政年份:2022
- 资助金额:
$ 11.79万 - 项目类别:
Alliance Grants
CGS-M Research Proposal: Cameron Burns
CGS-M 研究提案:Cameron Burns
- 批准号:
575892-2022 - 财政年份:2022
- 资助金额:
$ 11.79万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Implementation of Negative Pressure for Acute Paediatric Burns
负压治疗小儿急性烧伤的实施
- 批准号:
nhmrc : 2006970 - 财政年份:2021
- 资助金额:
$ 11.79万 - 项目类别:
Partnership Projects
Next-generation smart wound dressings for real-time, non-invasive monitoring of infection and neovascularisation in burns
下一代智能伤口敷料,用于实时、非侵入性监测烧伤感染和新生血管形成
- 批准号:
nhmrc : 2002254 - 财政年份:2021
- 资助金额:
$ 11.79万 - 项目类别:
Ideas Grants
Controlling inflammatory response: Using innovative peptides and nanoparticle technology to significantly reduce the damage and impact on skin of 2nd and 3rd degree burns
控制炎症反应:利用创新肽和纳米颗粒技术,显着减少二度和三度烧伤对皮肤的损伤和影响
- 批准号:
10024847 - 财政年份:2021
- 资助金额:
$ 11.79万 - 项目类别:
Collaborative R&D